Warner Pharma announced that the company plans to issue A shares to specific targets, raising a total of no more than RMB 500 million (including the amount). The issuance objects of this issue are Hunan Warner Zhi Zhen Industrial Investment Partnership (Limited Partnership). The issuance object will subscribe to the shares issued this time in cash. Among them, Warner Zhi Zhen plans to subscribe for no more than RMB 500 million (including the amount). As of the announcement date, Warner Zhizhen was a related party controlled by the actual controller of the company, Huang Bendong, and was a related transaction in accordance with the listing rules for sci-tech innovation Board stocks of the Shanghai Stock Exchange.
华纳药厂：拟向实控人黄本东控制的华纳至臻定增募资不超5亿元
Warner Pharma plans to raise no more than 500 million yuan from its Warner to the ultimate Controling shareholder Huang Bendong.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.